Skip to main content

Table 3 The numbers and percentages of polymorphous low-grade adenocarcinomas in malignant minor salivary gland tumors by country as described in the studies included in this review

From: Polymorphous low-grade adenocarcinoma: an analysis of epidemiological studies and hints for pathologists

Country

MMSGTs

PLGA

PLGA/MMSGTs

 

n

%

n

%

%

Australia

30

0.4

6

1.4

20.0

Austria

32

0.5

0

0.0

0.0

Brazil

356

5.2

20

4.6

5.6

China

2,683

38.9

83

19.3

3.1

Croatia

210

3.0

4

0.9

1.9

Denmark

266

3.9

66

15.3

24.8

Ecuador

14

0.2

0

0.0

0.0

England

384

5.6

33

7.7

8.6

Finland

118

1.7

19

4.4

16.1

German

226

3.3

29

6.7

12.8

India

197

2.9

18

4.2

9.1

Iran

16

0.2

0

0.0

0.0

Israel

104

1.5

11

2.6

10.6

Italy

50

0.7

1

0.2

2.0

Japan

98

1.4

0

0.0

0.0

Jordan

20

0.3

0

0.0

0.0

Kenya

58

0.8

0

0.0

0.0

Mexico

77

1.1

0

0.0

0.0

Niger

73

1.1

7

1.6

9.6

Paquistan

70

1.0

2

0.5

2.9

Sri Lanka

276

4.0

27

6.3

9.8

Switzerland

27

0.4

0

0.0

0.0

Tanzania

37

0.5

0

0.0

0.0

Thailand

201

2.9

3

0.7

1.5

Uganda

47

0.7

7

1.6

14.9

USA

1,193

17.3

95

22.0

8.0

Venezuela

28

0.4

0

0.0

0.0

Total

6,891

100.0

431

100.0

6.3

  1. MMSGTs: malignant minor salivary gland tumors; PLGA: polymorphous low-grade adenocarcinoma.